These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26334738)

  • 1. Systemic Immune Activation and HIV Shedding in the Female Genital Tract.
    Spencer LY; Christiansen S; Wang CH; Mack WJ; Young M; Strickler HD; Anastos K; Minkoff H; Cohen M; Geenblatt RM; Karim R; Operskalski E; Frederick T; Homans JD; Landay A; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):155-62. PubMed ID: 26334738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of HIV-1 shedding in the genital tract of women.
    Kovacs A; Wasserman SS; Burns D; Wright DJ; Cohn J; Landay A; Weber K; Cohen M; Levine A; Minkoff H; Miotti P; Palefsky J; Young M; Reichelderfer P; ;
    Lancet; 2001 Nov; 358(9293):1593-601. PubMed ID: 11716886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen.
    Meditz AL; Palmer C; Predhomme J; Searls K; Kerr B; Seifert S; Caraway P; Gardner EM; MaWhinney S; Anderson PL
    AIDS Res Hum Retroviruses; 2015 Oct; 31(10):1015-22. PubMed ID: 26059647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding.
    Jaspan HB; Liebenberg L; Hanekom W; Burgers W; Coetzee D; Williamson AL; Little F; Myer L; Coombs RW; Sodora D; Passmore JA
    J Infect Dis; 2011 Nov; 204(10):1550-6. PubMed ID: 21940422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.
    Gibbs A; Hirbod T; Li Q; Bohman K; Ball TB; Plummer FA; Kaul R; Kimani J; Broliden K; Tjernlund A
    J Immunol; 2014 Apr; 192(8):3947-57. PubMed ID: 24639358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.
    Bull ME; Legard J; Tapia K; Sorensen B; Cohn SE; Garcia R; Holte SE; Coombs RW; Hitti JE
    J Acquir Immune Defic Syndr; 2014 Dec; 67(4):357-64. PubMed ID: 25202922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.
    Graham SM; Jalalian-Lechak Z; Shafi J; Chohan V; Deya RW; Jaoko W; Mandaliya KN; Peshu NM; Overbaugh J; McClelland RS
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):511-8. PubMed ID: 22592588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts.
    Coleman JS; Hitti J; Bukusi EA; Mwachari C; Muliro A; Nguti R; Gausman R; Jensen S; Patton D; Lockhart D; Coombs R; Cohen CR
    AIDS; 2007 Mar; 21(6):755-9. PubMed ID: 17413697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding.
    Hawes SE; Sow PS; Stern JE; Critchlow CW; Gottlieb GS; Kiviat NB
    AIDS; 2008 Nov; 22(18):2517-25. PubMed ID: 19005275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy.
    King CC; Ellington SR; Davis NL; Coombs RW; Pyra M; Hong T; Mugo N; Patel RC; Lingappa JR; Baeten JM; Kourtis AP;
    J Infect Dis; 2017 Dec; 216(12):1534-1540. PubMed ID: 29240922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.
    Sheth AN; Evans-Strickfaden T; Haaland R; Martin A; Gatcliffe C; Adesoye A; Omondi MW; Lupo LD; Danavall D; Easley K; Chen CY; Pau CP; Hart C; Ofotokun I
    J Infect Dis; 2014 Sep; 210(5):736-44. PubMed ID: 24643223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
    Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
    AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
    Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.
    Keller MJ; McGinn AP; Lo Y; Huber A; Espinoza L; Minkoff H; Colie C; Nowicki MJ; D'Souza G; Anastos K
    Am J Reprod Immunol; 2016 Jun; 75(6):631-42. PubMed ID: 27145926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital tract leukocytes and shedding of genital HIV type 1 RNA.
    Anderson BL; Wang CC; Delong AK; Liu T; Kojic EM; Kurpewski J; Ingersoll J; Mayer K; Caliendo AM; Cu-Uvin S
    Clin Infect Dis; 2008 Nov; 47(9):1216-21. PubMed ID: 18808359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.
    Ondoa P; Gautam R; Rusine J; Lutter R; Jurriaans S; Kootstra N; Karita E; van de Wijgert J
    PLoS One; 2015; 10(5):e0127201. PubMed ID: 26010956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1.
    Wolday D; Gebremariam Z; Mohammed Z; Dorigo-Zetsma W; Meles H; Messele T; Geyid A; Sanders E; Maayan S
    AIDS; 2004 Mar; 18(5):781-5. PubMed ID: 15075513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
    Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
    J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.